Financial Balance Has Improved, But Provider Deficits Remain Concentrated

6 Jul 2026

Share with

June blog - 3

NHS England’s Month 12 Financial Position for 2025/26 shows a system that has materially strengthened financial grip.

After draft plans submitted in February 2025 showed a £4.4 billion deficit, final plans were submitted at break-even following a leadership and financial reset. By year end, NHS England reported a £70 million national underspend against the non-ringfenced Revenue Departmental Expenditure Limit.

That is a significant system signal. NHS England also reports that this was delivered without drawing on a reserve claim from HM Treasury, which it presents as evidence of improved control, stronger accountability and greater confidence from government partners.

But national balance does not mean local financial ease. Within the overall position, systems still delivered a £563 million deficit, and the five largest deficit systems accounted for 88% of the total system deficit. Provider overspends, efficiency shortfalls and workforce cost pressures remain central features of the financial picture.

The June Board papers therefore show a more disciplined financial system, but not a financially comfortable one. For provider and system leaders, 2026/27 is likely to be defined by the challenge of sustaining operational recovery while living within tighter financial expectations.

Reading the financial position in context

The Month 12 position is an important financial control signal, but it should not be read as a complete measure of underlying provider resilience.

NHS England reports a £70 million national underspend, equivalent to 0.035% of the relevant revenue position. That is a narrow margin in the context of total NHS expenditure, and the figures are unaudited at this stage. The position also sits alongside system overspends of £563 million and a broader system deficit of £813 million before the effect of held-back deficit support funding and delegated specialised commissioning.

This distinction matters. A national underspend can demonstrate grip at aggregate level while still coexisting with local deficits, non-recurrent recovery actions, constrained capital investment, workforce cost pressure and uneven provider performance. It can also mask the difference between meeting a control total in-year and achieving a sustainable underlying position.

Recent sector reporting points to continuing financial pressure beneath the national outturn. HSJ has reported that NHS England was planning for a £1.5 billion local deficit in 2026/27 and still needed to find a further £300 million through ongoing negotiations. It also reported that cash support to keep trust services running had risen to £1.1 billion, despite NHS England stating that provider finances had improved. These reports reinforce the need to distinguish between national financial control, provider-level deficit recovery and liquidity pressures affecting local services.

The Board paper should therefore be read as evidence that national financial discipline strengthened during 2025/26, not as evidence that financial pressure has been resolved across providers and systems.

National financial grip has strengthened

The headline position is clear. NHS England reports that the NHS ended 2025/26 with a £70 million underspend at national level.

This matters because the starting point for the year was materially more difficult. Draft financial plans had totalled a £4.4 billion deficit. Gross of deficit support funding, the figure was £6.6 billion, before interventions, board-to-board discussions and the financial reset moved final plans to break-even.

NHS England also reports several improvements across the year. The level of overspend in frontline organisations reduced by more than one third. The number of organisations delivering plan increased from 70% to nearly 80%. Efficiency delivery rose from £8.6 billion to £10.2 billion. Agency spend was almost halved, falling from £2.1 billion to £1.2 billion.

These are important indicators of stronger financial control. They suggest that the system has become more effective at setting expectations, intervening earlier and maintaining discipline against plan.

The agency reduction is a legitimate financial control achievement, but it should not be interpreted as proof that workforce cost pressure has disappeared. The same Month 12 paper identifies workforce costs above planned levels as one of the drivers of system overspends. The more balanced reading is that NHS England has tightened one visible area of temporary staffing expenditure, while the wider workforce cost base remains a live pressure for many providers.

The policy intent is also clear. Financial grip is being used to support sustainability, productivity and accountability. In a constrained public finance environment, the NHS is expected to demonstrate that increased activity, improved access and service transformation can be delivered within available resources.

Local deficits remain highly concentrated

The more challenging signal sits beneath the national position.

NHS England reports system overspends of £563 million within the overall revenue position. The broader system deficit including deficit support funding was £813 million, reducing to £563 million once withheld deficit support funding and delegated specialised commissioning were included.

The concentration of deficit is notable. NHS England states that the five systems with the largest deficits — Kent and Medway, Cheshire and Merseyside, Nottingham and Nottinghamshire, Humber and North Yorkshire, and Hampshire and Isle of Wight — were responsible for 88% of the total system deficit.

This concentration matters for system leadership. It suggests that financial pressure is not evenly distributed. Some systems have moved closer to plan, while a smaller number continue to carry a disproportionate share of the deficit.

Wider policy analysis also supports a cautious reading of the national position. Provider deficits have been a recurring concern in recent years, and external analysis has highlighted the fragility of NHS provider finances after the temporary pandemic-period improvement. This wider context matters because the NHS can report aggregate control while individual providers and systems continue to face structural financial pressure.

That has operational implications. Systems with persistent deficits are likely to face more intensive scrutiny, tighter controls, stronger oversight and greater pressure to deliver recovery trajectories. Provider boards in those systems will need to show clear grip on workforce costs, efficiency delivery, productivity, elective activity, continuing healthcare expenditure and underlying demand.

Efficiency delivery improved, but fell short of plan

The financial position also shows the scale of the productivity challenge.

Systems delivered £10.2 billion of efficiencies in 2025/26. This was 92% of the planned level and represented a £1.6 billion increase on 2024/25. However, it was still £842 million below the planned efficiency requirement of £11.2 billion.

This is one of the most important signals in the Board pack. The NHS is delivering more efficiency than before, but the planned efficiency requirement is also very high. Closing that gap is likely to become harder over time as easier controls are exhausted.

The composition of efficiencies also matters. A savings programme built mainly on non-recurrent actions, vacancy management or delayed expenditure is less sustainable than one based on recurrent productivity improvement and pathway redesign. The Board paper shows the scale of efficiency delivered, but the critical question for 2026/27 is how much of that improvement can be repeated without reducing capacity or increasing operational risk.

In 2025/26, agency spend reduction made a material contribution to improved grip. But future gains will increasingly need to come from deeper operational change: pathway redesign, theatre productivity, outpatient transformation, diagnostic flow, discharge optimisation, procurement discipline, workforce deployment and reduction of unwarranted variation.

This is where financial recovery becomes operational recovery. The system cannot rely solely on cost controls. It must convert financial discipline into better use of capacity, better scheduling, better workforce models and more consistent delivery across providers.

Workforce cost control remains central, but sensitive

NHS England identifies workforce costs above planned levels as one of the drivers of system overspends. It also highlights the financial impact of industrial action, including increased staff cover costs during strikes.

At the same time, the wider Board pack shows why workforce control cannot be treated only as a cost exercise. Staff engagement has weakened, sickness absence remains an area of focus, and NHS England itself is managing substantial organisational transition through voluntary redundancy and pre-integration with the Department of Health and Social Care.

The system incentive is therefore finely balanced. The financial objective is to reduce avoidable temporary staffing cost, improve productivity and maintain grip. The operational trade-off is that providers still need safe staffing, resilient rotas and sufficient clinical capacity to deliver elective, urgent, diagnostic and cancer recovery.

This is also why agency reduction should be viewed through a whole-cost lens. A lower agency bill is important, but it does not by itself show whether the total cost of maintaining clinical capacity has reduced. Providers may still be carrying pressure through bank staffing, overtime, premium substantive cover, outsourced clinical activity, independent sector use, or other purchased healthcare routes. The key financial question is not only whether one category of temporary staffing spend has fallen, but whether the system has reduced avoidable cost without weakening safe capacity or displacing pressure into less visible parts of the accounts.

If workforce cost control is implemented without attention to safe deployment and staff experience, it may create pressure elsewhere: cancellations, delayed care, escalation failures, staff fatigue, or greater reliance on more expensive short-notice cover. Conversely, if temporary staffing is used without strong governance and productivity discipline, financial recovery becomes harder to sustain.

The most credible position is not simply “less temporary staffing”. It is better workforce planning, better deployment, stronger controls, and clinically governed use of flexible capacity where it protects safety, access and continuity.

Productivity is becoming the bridge between finance and performance

The Integrated Performance Report shows why productivity is now central to the financial outlook.

The report states that acute providers were delivering a provisional implied productivity estimate of 2.8% at Month 10 year-to-date, above the Government’s minimum 2% target. It also notes variation between providers and continued data-quality limitations.

This is likely to be a defining theme for 2026/27. Financial balance will depend less on isolated savings programmes and more on whether providers can deliver sustained productivity gains while maintaining quality.

The productivity opportunity is broad. It includes increasing effective clinical activity, reducing avoidable variation, improving utilisation, using diagnostics and theatres efficiently, reducing length of stay, improving discharge, managing outpatient follow-up, and aligning workforce deployment to demand.

But productivity must be interpreted carefully. It cannot simply mean asking staff to do more with less. Sustainable productivity depends on good operational design, reliable data, leadership discipline and workforce engagement. It also depends on understanding where productivity improvement is clinically appropriate and where additional investment or capacity is needed to unlock flow.

Capital constraint and estates risk remain part of the financial picture

The Board papers also highlight that finance is not only a revenue issue.

The Strategic Risk Register identifies capital availability as a major strategic risk. It states that 45% of estates infrastructure is not fit for the services the NHS delivers today, is not aligned to population needs and is subject to continued failure. This has a direct impact on clinical productivity and presents risks to patient and staff safety.

Wider estates data reinforces the same concern. Recent analysis of the Estates Returns Information Collection has highlighted the scale of the NHS secondary care maintenance backlog, including high-risk backlog maintenance linked to potential major disruption or service failure. This means capital constraint is not a background estates issue; it directly affects the realism of productivity, access and safety expectations.

The Month 12 finance paper reports that providers spent £9.174 billion on capital schemes during 2025/26, representing 98% of their full-year budget. NHS England also reports an underspend against the Department of Health and Social Care provider and commissioning capital budget.

Capital constraints matter because they shape the realism of productivity and transformation expectations. Providers may be asked to improve flow, increase activity, reduce waits and shift care closer to home, while operating from estates that are not designed for modern pathways.

The financial implication is that some deficits and productivity gaps are not simply management failures. They may reflect structural constraints: estate configuration, digital maturity, workforce availability, diagnostic infrastructure and local demand patterns. Strong grip is still required, but recovery plans must distinguish between controllable inefficiency and constraints that require capital, redesign or system-level intervention.

What this means now

The June 2026 financial position shows a system that has improved control but remains under pressure.

The national underspend is important. It demonstrates stronger financial discipline and suggests that the reset during 2025/26 had real impact. The reduction in agency spend and improvement in efficiency delivery are also significant.

But provider and system deficits remain concentrated, efficiency delivery still fell short of plan, and workforce costs continue to create financial pressure. Recent sector reporting on planned 2026/27 local deficits and cash support for trusts also reinforces that the forward financial position remains challenging.

At the same time, the wider system is being asked to improve access, reduce long waits, recover diagnostics, strengthen quality, manage transition and deliver productivity.

For provider leadership, the message is clear: financial grip is now inseparable from operational grip. Boards will need to show that recovery plans are credible, data-led and connected to real delivery mechanisms. They will need to understand where cost pressure is driven by poor productivity, where it reflects unavoidable demand, and where it arises from structural constraints such as workforce, diagnostics, estates or digital maturity.

For patients, the benefit of stronger financial discipline should be a more sustainable system: less waste, better prioritisation and more reliable delivery. The risk is that short-term cost control, if poorly designed, could reduce capacity or create pressure in already stretched pathways.

For healthcare workers, the challenge is that financial recovery can feel like another layer of pressure unless it is matched with credible workforce planning, safe staffing and practical operational support.

The forward outlook is disciplined but demanding. The NHS has shown it can restore national balance. The harder task in 2026/27 will be sustaining that balance while improving access, protecting quality and reducing variation in the systems and providers where financial pressure remains most concentrated.

References

  • NHS England, Month 12 Financial Position 2025/26, 4 June 2026.
  • NHS England, Integrated Performance Report, June 2026.
  • NHS England, Risk Management, 4 June 2026.
  • NHS England, NHS England Strategic Risk Register, Annex 1, 4 June 2026.
  • NHS England, NHS England Operational Risk Register, Annex 2, 4 June 2026.
  • Department of Health and Social Care, 2025 to 2026 revised financial directions to NHS England, March 2026.
  • The King’s Fund, NHS Funding Deficits.
  • Nuffield Trust, NHS Provider Deficits Are Back: How Bad Is the Situation?
  • The King’s Fund, NHS Estates Backlog and Capital Constraint Analysis.
  • HSJ, Revealed: NHSE Planning for £1.5bn Local Deficit, June 2026.
  • HSJ, Cash Bailouts Hit £1.1bn Despite Falling Deficit, May 2026.

06 Jul 2026 | Leave a comment

Share with socials

Leave a Comment

You must be logged in to post a comment.